Annual FCF
-$26.80 M
+$12.93 M+32.54%
01 July 2024
Summary:
Enzo Biochem annual free cash flow is currently -$26.80 million, with the most recent change of +$12.93 million (+32.54%) on 01 July 2024. During the last 3 years, it has fallen by -$22.75 million (-561.99%). ENZ annual FCF is now -151.95% below its all-time high of $51.60 million, reached on 31 July 2016.ENZ Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$1.21 M
+$1.80 M+59.80%
01 July 2024
Summary:
Enzo Biochem quarterly free cash flow is currently -$1.21 million, with the most recent change of +$1.80 million (+59.80%) on 01 July 2024. Over the past year, it has increased by +$12.42 million (+91.14%). ENZ quarterly FCF is now -103.36% below its all-time high of $35.98 million, reached on 31 July 2016.ENZ Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$26.80 M
+$16.40 M+37.95%
01 July 2024
Summary:
Enzo Biochem TTM free cash flow is currently -$26.80 million, with the most recent change of +$16.40 million (+37.95%) on 01 July 2024. Over the past year, it has increased by +$17.21 million (+39.11%). ENZ TTM FCF is now -151.95% below its all-time high of $51.60 million, reached on 31 July 2016.ENZ TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENZ Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +32.5% | +91.1% | +39.1% |
| 3 y3 years | -562.0% | +82.9% | -188.2% |
| 5 y5 years | -707.4% | +48.4% | -2921.5% |
ENZ Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -562.0% | +32.5% | at high | +93.1% | -188.2% | +41.6% |
| 5 y | 5 years | -707.4% | +32.5% | -315.7% | +93.1% | -367.6% | +41.6% |
| alltime | all time | -151.9% | +32.5% | -103.4% | +93.1% | -151.9% | +41.6% |
Enzo Biochem Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| July 2024 | -$26.80 M(-32.5%) | -$1.21 M(-59.8%) | -$26.80 M(-38.0%) |
| Apr 2024 | - | -$3.00 M(-66.5%) | -$43.20 M(-5.9%) |
| Jan 2024 | - | -$8.96 M(-34.2%) | -$45.91 M(+4.3%) |
| Oct 2023 | - | -$13.63 M(-22.6%) | -$44.02 M(+10.8%) |
| July 2023 | -$39.74 M(+98.1%) | -$17.60 M(+207.8%) | -$39.74 M(+25.9%) |
| Apr 2023 | - | -$5.72 M(-19.1%) | -$31.57 M(+14.6%) |
| Jan 2023 | - | -$7.07 M(-24.4%) | -$27.55 M(+23.4%) |
| Oct 2022 | - | -$9.35 M(-1.0%) | -$22.33 M(+11.3%) |
| July 2022 | -$20.06 M(+395.5%) | -$9.44 M(+454.3%) | -$20.06 M(+66.1%) |
| Apr 2022 | - | -$1.70 M(-7.6%) | -$12.08 M(+23.0%) |
| Jan 2022 | - | -$1.84 M(-73.9%) | -$9.82 M(+5.6%) |
| Oct 2021 | - | -$7.08 M(+385.3%) | -$9.30 M(+129.7%) |
| July 2021 | -$4.05 M(-79.1%) | -$1.46 M(-360.4%) | -$4.05 M(-55.5%) |
| Apr 2021 | - | $560.00 K(-142.2%) | -$9.10 M(-35.3%) |
| Jan 2021 | - | -$1.33 M(-27.3%) | -$14.07 M(-25.3%) |
| Oct 2020 | - | -$1.82 M(-72.0%) | -$18.83 M(-2.7%) |
| July 2020 | -$19.35 M(+482.8%) | -$6.51 M(+47.6%) | -$19.35 M(+16.7%) |
| Apr 2020 | - | -$4.41 M(-27.5%) | -$16.58 M(-265.5%) |
| Jan 2020 | - | -$6.08 M(+160.0%) | $10.02 M(+954.5%) |
| Oct 2019 | - | -$2.34 M(-37.6%) | $950.00 K(-128.6%) |
| July 2019 | -$3.32 M(-28.2%) | -$3.75 M(-116.9%) | -$3.32 M(+58.5%) |
| Apr 2019 | - | $22.19 M(-246.4%) | -$2.10 M(-92.0%) |
| Jan 2019 | - | -$15.15 M(+129.2%) | -$26.16 M(+95.7%) |
| Oct 2018 | - | -$6.61 M(+162.1%) | -$13.37 M(+189.1%) |
| July 2018 | -$4.62 M(+136.1%) | -$2.52 M(+34.9%) | -$4.62 M(+523.9%) |
| Apr 2018 | - | -$1.87 M(-20.9%) | -$741.00 K(-155.6%) |
| Jan 2018 | - | -$2.37 M(-210.8%) | $1.33 M(+30.2%) |
| Oct 2017 | - | $2.13 M(+56.9%) | $1.02 M(-152.2%) |
| July 2017 | -$1.96 M(-103.8%) | $1.36 M(+570.0%) | -$1.96 M(-106.0%) |
| Apr 2017 | - | $203.00 K(-107.6%) | $32.66 M(+12.8%) |
| Jan 2017 | - | -$2.67 M(+215.7%) | $28.95 M(-24.0%) |
| Oct 2016 | - | -$847.00 K(-102.4%) | $38.10 M(-26.2%) |
| July 2016 | $51.60 M(-1041.0%) | $35.98 M(-1126.3%) | $51.60 M(+165.0%) |
| Apr 2016 | - | -$3.51 M(-154.2%) | $19.47 M(-6.2%) |
| Jan 2016 | - | $6.47 M(-48.8%) | $20.76 M(+103.9%) |
| Oct 2015 | - | $12.65 M(+228.1%) | $10.18 M(-285.7%) |
| July 2015 | -$5.48 M(+116.3%) | $3.85 M(-274.2%) | -$5.48 M(-36.0%) |
| Apr 2015 | - | -$2.21 M(-46.1%) | -$8.57 M(+89.9%) |
| Jan 2015 | - | -$4.11 M(+36.0%) | -$4.51 M(+136.0%) |
| Oct 2014 | - | -$3.02 M(-492.6%) | -$1.91 M(-24.6%) |
| July 2014 | -$2.54 M(-77.0%) | $769.00 K(-58.3%) | -$2.54 M(-49.5%) |
| Apr 2014 | - | $1.84 M(-222.4%) | -$5.02 M(-54.3%) |
| Jan 2014 | - | -$1.51 M(-58.6%) | -$10.99 M(-14.7%) |
| Oct 2013 | - | -$3.64 M(+112.2%) | -$12.88 M(+17.0%) |
| July 2013 | -$11.00 M(+50.0%) | -$1.72 M(-58.4%) | -$11.00 M(+19.0%) |
| Apr 2013 | - | -$4.13 M(+21.5%) | -$9.25 M(+10.1%) |
| Jan 2013 | - | -$3.40 M(+92.0%) | -$8.40 M(+28.3%) |
| Oct 2012 | - | -$1.77 M(-4633.3%) | -$6.55 M(-10.7%) |
| July 2012 | -$7.34 M(-23.2%) | $39.00 K(-101.2%) | -$7.34 M(-31.7%) |
| Apr 2012 | - | -$3.28 M(+112.4%) | -$10.74 M(-1.4%) |
| Jan 2012 | - | -$1.54 M(-39.6%) | -$10.89 M(+8.1%) |
| Oct 2011 | - | -$2.55 M(-24.0%) | -$10.08 M(+5.6%) |
| July 2011 | -$9.55 M(-42.9%) | -$3.36 M(-2.1%) | -$9.55 M(+34.6%) |
| Apr 2011 | - | -$3.44 M(+371.2%) | -$7.09 M(-48.2%) |
| Jan 2011 | - | -$729.00 K(-64.0%) | -$13.69 M(-7.3%) |
| Oct 2010 | - | -$2.02 M(+123.5%) | -$14.76 M(-11.7%) |
| July 2010 | -$16.71 M(+17.8%) | -$905.00 K(-91.0%) | -$16.71 M(-12.5%) |
| Apr 2010 | - | -$10.03 M(+456.4%) | -$19.10 M(+34.1%) |
| Jan 2010 | - | -$1.80 M(-54.7%) | -$14.24 M(-10.2%) |
| Oct 2009 | - | -$3.98 M(+20.7%) | -$15.87 M(+11.9%) |
| July 2009 | -$14.19 M(+20.3%) | -$3.29 M(-36.3%) | -$14.19 M(+0.6%) |
| Apr 2009 | - | -$5.17 M(+50.8%) | -$14.11 M(+30.8%) |
| Jan 2009 | - | -$3.43 M(+49.4%) | -$10.79 M(-13.8%) |
| Oct 2008 | - | -$2.29 M(-28.6%) | -$12.52 M(+6.1%) |
| July 2008 | -$11.79 M(+126.2%) | -$3.21 M(+73.4%) | -$11.79 M(+74.1%) |
| Apr 2008 | - | -$1.85 M(-64.1%) | -$6.77 M(-31.6%) |
| Jan 2008 | - | -$5.16 M(+227.7%) | -$9.90 M(+10.4%) |
| Oct 2007 | - | -$1.57 M(-187.0%) | -$8.97 M(+72.0%) |
| July 2007 | -$5.21 M | $1.81 M(-136.3%) | -$5.21 M(-60.9%) |
| Apr 2007 | - | -$4.98 M(+17.9%) | -$13.32 M(+46.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jan 2007 | - | -$4.22 M(-293.5%) | -$9.11 M(-7.8%) |
| Oct 2006 | - | $2.18 M(-134.6%) | -$9.88 M(-31.4%) |
| July 2006 | -$14.40 M(-221.6%) | -$6.30 M(+716.9%) | -$14.40 M(+224.2%) |
| Apr 2006 | - | -$771.00 K(-84.6%) | -$4.44 M(-13.3%) |
| Jan 2006 | - | -$5.00 M(+113.8%) | -$5.13 M(-9.6%) |
| Oct 2005 | - | -$2.34 M(-163.8%) | -$5.67 M(-147.9%) |
| July 2005 | $11.84 M(-272.0%) | $3.66 M(-352.0%) | $11.84 M(+144.6%) |
| Apr 2005 | - | -$1.45 M(-73.8%) | $4.84 M(-25.5%) |
| Jan 2005 | - | -$5.54 M(-136.5%) | $6.50 M(-21.2%) |
| Oct 2004 | - | $15.18 M(-554.4%) | $8.25 M(-219.8%) |
| July 2004 | -$6.89 M(-161.8%) | -$3.34 M(-1729.3%) | -$6.89 M(+47.7%) |
| Apr 2004 | - | $205.00 K(-105.4%) | -$4.66 M(+204.7%) |
| Jan 2004 | - | -$3.79 M(-9131.0%) | -$1.53 M(-130.5%) |
| Oct 2003 | - | $42.00 K(-103.8%) | $5.02 M(-54.9%) |
| July 2003 | $11.15 M(+24.7%) | -$1.11 M(-133.4%) | $11.15 M(-30.3%) |
| Apr 2003 | - | $3.34 M(+20.9%) | $16.00 M(+10.9%) |
| Jan 2003 | - | $2.76 M(-55.3%) | $14.43 M(+15.6%) |
| Oct 2002 | - | $6.17 M(+65.0%) | $12.48 M(+39.6%) |
| July 2002 | $8.94 M(+28.0%) | $3.74 M(+112.1%) | $8.94 M(+22.4%) |
| Apr 2002 | - | $1.76 M(+117.3%) | $7.30 M(-4.5%) |
| Jan 2002 | - | $811.00 K(-69.1%) | $7.65 M(+3.5%) |
| Oct 2001 | - | $2.63 M(+24.9%) | $7.39 M(+5.9%) |
| July 2001 | $6.98 M(+68.6%) | $2.10 M(-0.2%) | $6.98 M(-13.4%) |
| Apr 2001 | - | $2.11 M(+280.7%) | $8.07 M(+25.8%) |
| Jan 2001 | - | $554.00 K(-75.0%) | $6.41 M(+2.5%) |
| Oct 2000 | - | $2.22 M(-30.5%) | $6.26 M(+51.1%) |
| July 2000 | $4.14 M(-58.6%) | $3.19 M(+603.8%) | $4.14 M(+68.8%) |
| Apr 2000 | - | $453.00 K(+13.3%) | $2.45 M(-33.7%) |
| Jan 2000 | - | $400.00 K(+300.0%) | $3.70 M(-14.0%) |
| Oct 1999 | - | $100.00 K(-93.3%) | $4.30 M(-57.0%) |
| July 1999 | $10.00 M(+29.9%) | $1.50 M(-11.8%) | $10.00 M(+8.7%) |
| Apr 1999 | - | $1.70 M(+70.0%) | $9.20 M(+7.0%) |
| Jan 1999 | - | $1.00 M(-82.8%) | $8.60 M(-2.3%) |
| Oct 1998 | - | $5.80 M(+728.6%) | $8.80 M(+14.3%) |
| July 1998 | $7.70 M(+10.0%) | $700.00 K(-36.4%) | $7.70 M(-7.2%) |
| Apr 1998 | - | $1.10 M(-8.3%) | $8.30 M(+9.2%) |
| Jan 1998 | - | $1.20 M(-74.5%) | $7.60 M(+26.7%) |
| Oct 1997 | - | $4.70 M(+261.5%) | $6.00 M(-14.3%) |
| July 1997 | $7.00 M(+29.6%) | $1.30 M(+225.0%) | $7.00 M(-1.4%) |
| Apr 1997 | - | $400.00 K(-200.0%) | $7.10 M(+10.9%) |
| Jan 1997 | - | -$400.00 K(-107.0%) | $6.40 M(-7.2%) |
| Oct 1996 | - | $5.70 M(+307.1%) | $6.90 M(+27.8%) |
| July 1996 | $5.40 M(-33.3%) | $1.40 M(-566.7%) | $5.40 M(+63.6%) |
| Apr 1996 | - | -$300.00 K(-400.0%) | $3.30 M(+57.1%) |
| Jan 1996 | - | $100.00 K(-97.6%) | $2.10 M(-275.0%) |
| Oct 1995 | - | $4.20 M(-700.0%) | -$1.20 M(-114.8%) |
| July 1995 | $8.10 M(-284.1%) | -$700.00 K(-53.3%) | $8.10 M(+1.3%) |
| Apr 1995 | - | -$1.50 M(-53.1%) | $8.00 M(+1.3%) |
| Jan 1995 | - | -$3.20 M(-123.7%) | $7.90 M(-22.5%) |
| Oct 1994 | - | $13.50 M(-1787.5%) | $10.20 M(-331.8%) |
| July 1994 | -$4.40 M(+4300.0%) | -$800.00 K(-50.0%) | -$4.40 M(+12.8%) |
| Apr 1994 | - | -$1.60 M(+77.8%) | -$3.90 M(+85.7%) |
| Jan 1994 | - | -$900.00 K(-18.2%) | -$2.10 M(+61.5%) |
| Oct 1993 | - | -$1.10 M(+266.7%) | -$1.30 M(+1200.0%) |
| July 1993 | -$100.00 K(-133.3%) | -$300.00 K(-250.0%) | -$100.00 K(-200.0%) |
| Apr 1993 | - | $200.00 K(-300.0%) | $100.00 K(-66.7%) |
| Jan 1993 | - | -$100.00 K(-200.0%) | $300.00 K(-70.0%) |
| Oct 1992 | - | $100.00 K(-200.0%) | $1.00 M(+233.3%) |
| July 1992 | $300.00 K(-103.4%) | -$100.00 K(-125.0%) | $300.00 K(-40.0%) |
| Apr 1992 | - | $400.00 K(-33.3%) | $500.00 K(-135.7%) |
| Jan 1992 | - | $600.00 K(-200.0%) | -$1.40 M(-68.9%) |
| Oct 1991 | - | -$600.00 K(-700.0%) | -$4.50 M(-48.9%) |
| July 1991 | -$8.80 M(-31.8%) | $100.00 K(-106.7%) | -$8.80 M(-36.7%) |
| Apr 1991 | - | -$1.50 M(-40.0%) | -$13.90 M(-12.0%) |
| Jan 1991 | - | -$2.50 M(-49.0%) | -$15.80 M(+1.3%) |
| Oct 1990 | - | -$4.90 M(-2.0%) | -$15.60 M(+20.9%) |
| July 1990 | -$12.90 M(-5.1%) | -$5.00 M(+47.1%) | -$12.90 M(+63.3%) |
| Apr 1990 | - | -$3.40 M(+47.8%) | -$7.90 M(+75.6%) |
| Jan 1990 | - | -$2.30 M(+4.5%) | -$4.50 M(+104.5%) |
| Oct 1989 | - | -$2.20 M | -$2.20 M |
| July 1989 | -$13.60 M | - | - |
FAQ
- What is Enzo Biochem annual free cash flow?
- What is the all time high annual FCF for Enzo Biochem?
- What is Enzo Biochem annual FCF year-on-year change?
- What is Enzo Biochem quarterly free cash flow?
- What is the all time high quarterly FCF for Enzo Biochem?
- What is Enzo Biochem quarterly FCF year-on-year change?
- What is Enzo Biochem TTM free cash flow?
- What is the all time high TTM FCF for Enzo Biochem?
- What is Enzo Biochem TTM FCF year-on-year change?
What is Enzo Biochem annual free cash flow?
The current annual FCF of ENZ is -$26.80 M
What is the all time high annual FCF for Enzo Biochem?
Enzo Biochem all-time high annual free cash flow is $51.60 M
What is Enzo Biochem annual FCF year-on-year change?
Over the past year, ENZ annual free cash flow has changed by +$12.93 M (+32.54%)
What is Enzo Biochem quarterly free cash flow?
The current quarterly FCF of ENZ is -$1.21 M
What is the all time high quarterly FCF for Enzo Biochem?
Enzo Biochem all-time high quarterly free cash flow is $35.98 M
What is Enzo Biochem quarterly FCF year-on-year change?
Over the past year, ENZ quarterly free cash flow has changed by +$12.42 M (+91.14%)
What is Enzo Biochem TTM free cash flow?
The current TTM FCF of ENZ is -$26.80 M
What is the all time high TTM FCF for Enzo Biochem?
Enzo Biochem all-time high TTM free cash flow is $51.60 M
What is Enzo Biochem TTM FCF year-on-year change?
Over the past year, ENZ TTM free cash flow has changed by +$17.21 M (+39.11%)